000 01379 a2200397 4500
005 20250517064949.0
264 0 _c20161005
008 201610s 0 0 eng d
022 _a1874-1754
024 7 _a10.1016/j.ijcard.2015.11.060
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLopatin, Yuri M
245 0 0 _aRationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
_h[electronic resource]
260 _bInternational journal of cardiology
_cJan 2016
300 _a909-15 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aEnergy Metabolism
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMyocardium
_xmetabolism
650 0 4 _aPrognosis
650 0 4 _aTreatment Outcome
650 0 4 _aTrimetazidine
_xpharmacokinetics
650 0 4 _aVasodilator Agents
_xpharmacokinetics
700 1 _aRosano, Giuseppe M C
700 1 _aFragasso, Gabriele
700 1 _aLopaschuk, Gary D
700 1 _aSeferovic, Petar M
700 1 _aGowdak, Luis Henrique W
700 1 _aVinereanu, Dragos
700 1 _aHamid, Magdy Abdel
700 1 _aJourdain, Patrick
700 1 _aPonikowski, Piotr
773 0 _tInternational journal of cardiology
_gvol. 203
_gp. 909-15
856 4 0 _uhttps://doi.org/10.1016/j.ijcard.2015.11.060
_zAvailable from publisher's website
999 _c25496496
_d25496496